Tracking clinical trial samples and consents to support total sample lifecycle management

Total Sample Lifecycle Management

Clinical Samples Have Complex Logistics & Lifecycle

Patient samples are the lifeblood of your clinical trials. Our unique software solution tracks these samples through their lifecycle across the ecosystem of sites, labs, biorepositories, and other trial partners. With the increase in importance of patient samples and consent, there is also a dramatic increase in complexity. This complexity stems from the number and variety of sample-based tests, “live” decision-making during the conduct of trials based on sample test results, and the globally distributed nature of the outsourced organizations that handle patient samples. As a result, researchers are facing a number of new challenges.


The Labmatrix® Clinical Trial Sample and Consent Tracking (CTST) system is a configurable and upgradable system that provides comprehensive sample lifecycle support for in-study sample and sample consent management and tracking, including future-use virtual or physical biorepositories (next generation biobanking) and data mining. Utilized in more than 1,000 trials to date, Labmatrix® offers sample-centric monitoring across a clinical trial’s entire ecosystem.


Traditional Central Lab Scope vs. Comprehensive CTST with Labmatrix®

Labmatrix® CTST


Using BioFortis Technology to Deliver Deeper and Broader Total Sample Management

  • Clinical Trial Sample and Consent Tracking (CTST)
  • Near Real-time Reconciliation of eClinical Data
  • In Study and Future use Sample Consent 
  • Virtual Biorepository

Labmatrix® CTST report families capture key narratives that illustrate the flow of study resources.




Discover how BioFortis, a Q2 Solutions Company, can help you unlock the potential of your specimens

Learn more

Related Thought Leaders Insights

Translational Science and Innovation Laboratory (TSAIL)

Located in the heart of the Research Triangle Park, Q2 Solutions’ state-of-the-art Translational Science and Innovation Laboratory (TSAIL) is designed for exploratory biomarker research and new...

Flexible Approaches for Biotech Companies in Clinical Trials

Small biotech companies have different clinical trials needs than larger sponsors. Biotech companies often have fewer staff members covering more roles with less specialization, and are developing...

Risk Management for Biotech Companies in Clinical Trials

When we discuss risk, it’s often focused on the negative threats where there is a need to mitigate or avoid threats to the project that could impact timelines, deliverables or quality. One can look...